Dr. Reddy’s Laboratories Ltd. Today announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
The Sensipar brand and generic market had U.S. sales of approximately $312 million MAT for the most recent twelve months ending in July 2020 according to IQVIA Health.
Dr. Reddy’s Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
DR.REDDY’S LABORATORIES ANNOUNCES THE LAUNCH OF CINACALCET TABLETS IN THE U.S. MARKET
